{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-126358","form_type":"8-K","ticker":"BJDX","cik":"0001704287","company_name":"Bluejay Diagnostics, Inc.","filed_at":"2025-12-30T23:59:59+00:00","discovered_at":"2026-05-14T18:02:40.204779+00:00","generated_at":"2026-05-16T12:00:17.362060+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Bluejay Diagnostics completes commercial-scale IL-6 antibody production for Symphony cartridges","bullets":["Completed commercial-scale production of polyclonal and monoclonal anti-IL-6 antibodies meeting internal performance criteria.","Antibodies intended for Symphony cartridge manufacturing for clinical and potential future commercial applications.","Sufficient material to support production of over 9 million Symphony cartridges; additional capacity established.","Symphony System remains under development, subject to further validation and FDA clearance before marketing.","Monoclonal antibodies designated as detection antibodies showed acceptable binding, specificity, and signal performance."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-126358","json":"https://secwatch.observer/filing/0001213900-25-126358.json","markdown":"https://secwatch.observer/filing/0001213900-25-126358.md","text":"https://secwatch.observer/filing/0001213900-25-126358.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1704287/000121390025126358/0001213900-25-126358-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1704287/000121390025126358/ea0271231-8k_bluejay.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T12:00:17.362060+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}